Cargando…
Early death in acute promyelocytic leukemia: time to redefine risk groups
Autores principales: | Salman, Meira Yisraeli, Ofran, Yishai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244806/ https://www.ncbi.nlm.nih.gov/pubmed/35081691 http://dx.doi.org/10.3324/haematol.2021.280446 |
Ejemplares similares
-
A chemotherapy-free regimen for Philadelphia chromosome-positive acute lymphoblastic leukemia: are we there yet?
por: Ofran, Yishai
Publicado: (2021) -
Acute Promyelocytic Leukemia
por: Thomas, Xavier, et al.
Publicado: (2020) -
Chasing quality remission in acute myeloid leukemia: intensity of induction and residual disease
por: Ofran, Yishai
Publicado: (2023) -
Timely diagnosis and treatment of acute promyelocytic leukemia should be available to all
por: Schuh, Andre C.
Publicado: (2021) -
Clinical characteristics of acute promyelocytic leukemia manifesting as early death
por: HE, BAI, et al.
Publicado: (2013)